Clinical Research Directory
Browse clinical research sites, groups, and studies.
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Sponsor: Gazi University
Summary
Prospective observational cohort study evaluating the early proctologic effects of GLP-1 receptor agonist therapy in morbidly obese patients. Participants will undergo baseline and 3-month anorectal symptom assessment and proctologic examination to evaluate newly developed proctologic diseases and changes in pre-existing symptoms.
Official title: Early Proctologic Effects of GLP-1 Receptor Agonist Therapy in Morbidly Obese Patients: A Prospective Cohort Study With Baseline and 3-Month Proctologic Assessment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-08
Completion Date
2027-05
Last Updated
2026-06-25
Healthy Volunteers
No
Conditions
Interventions
GLP-1 receptor agonist therapy
Participants will receive GLP-1 receptor agonist treatment as part of routine clinical care. The study does not assign treatment but prospectively evaluates proctologic outcomes following treatment initiation.
Locations (1)
Gazi University Faculty of Medicine
Ankara, Turkey (Türkiye)